Feasibility and efficacy of gemcitabine and docetaxel combination chemotherapy for bone and soft tissue sarcomas: multi-institutional retrospective analysis of 134 patients

BACKGROUND: Bone and soft tissue sarcomas (BSTS) are rare malignant tumors. Recently, the combination of gemcitabine and docetaxel (GD) was shown to have activity as second-line setting in BSTS. However, the efficacy as first-line and adjuvant settings and precise profiles of adverse events in Japan...

詳細記述

保存先:
書誌詳細
出版年:World J Surg Oncol
主要な著者: Tanaka, Kazuhiro, Joyama, Susumu, Chuman, Hirokazu, Hiraga, Hiroaki, Morioka, Hideo, Yoshikawa, Hideki, Hosaka, Masami, Takahashi, Mitsuru, Kubo, Tadahiko, Hatano, Hiroshi, Kaya, Mitsunori, Toguchida, Junya, Nishida, Yoshihiro, Nagano, Akihito, Tsumura, Hiroshi, Iwamoto, Yukihide
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2016
主題:
Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5146834/
https://ncbi.nlm.nih.gov/pubmed/27931230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-016-1059-2
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料